optometryadvisor14h
Targeted Geographic Atrophy Management Strategies Reduce Disease Progression
GA management involves identifying at-risk patients, assessing visual function, and referring for treatment when necessary.
WebMD1d
New Therapy Brings Hope for Dry AMD Vision Loss
The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
The Huntsville Item2d
Lineage Cell Therapeutics Issues Letter to Stockholders
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today published a letter to ...
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Receives Buy Rating from D. Boral Capital
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at ...
The Analyst Verdict: Lineage Cell Therapeutics In The Eyes Of 4 Experts
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $4.0, along with a high estimate of $9.00 and a low estimate of $2.00. No alteration is ...